Hayleigh Collins | Director and Head of Corporate Communications |
Sean Nolan | CEO |
Sukumar Nagendran | President and Head of Research and Development |
Salman Bhai | Assistant Professor of Neurology at UT |
Kamran Alam | CFO |
Abigail Gray | Baird |
Gil Blum | Needham & Co. |
Thank you for standing by. This is the conference operator. Welcome to the Taysha Gene Therapies First Quarter 2023 Earnings Conference Call.
As a reminder, all participants are in listen-only mode and the conference is being recorded. After the presentation, there'll be an opportunity to ask questions.